Cronos Group Inc (CRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRON | XERS | TBPH | ||
| Company | Cronos Group Inc | Xeris Pharmaceuticals Inc | Theravance Bio Ord | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.52 | 6.73 | 19.11 | ||
| High | 2.54 | 6.90 | 19.11 | ||
| Low | 2.49 | 6.65 | 18.59 | ||
| Latest | 2.49 | 6.72 | 18.70 | ||
| Change | -0.02 | -0.01 | -0.19 | ||
| % Change | -0.80% | -0.15% | -1.01% | ||
| Volume | 790,700 | 1,387,100 | 331,200 | ||
| 20-Day Average Volume | 1,198,010 | 2,843,835 | 608,710 | ||
| Previous Close | 2.51 | 6.73 | 18.89 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.46 | 7.14 | 18.01 | ||
| 20-Day Raw Stochastic | 65.63% | 10.09% | 71.99% | ||
| 20-Day Relative Strength | 50.71 | 37.67 | 60.76 | ||
| Weighted Alpha | +26.85 | +71.75 | +108.02 | ||
| Today's Opinion | 56% Buy | 8% Buy | 100% Buy | ||
| Previous Opinion | 56% Buy | 8% Buy | 100% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.40% since 11/26/25 | -6.41% since 11/26/25 | -6.31% since 11/26/25 | ||
| Low | 2.44 on 12/01/25 | 6.47 on 12/02/25 | 18.39 on 12/02/25 | ||
| High | 2.55 on 12/03/25 | 7.24 on 11/28/25 | 20.33 on 11/28/25 | ||
| 1-Month | |||||
| %Chg | +1.63% since 11/04/25 | -32.12% since 11/04/25 | +26.78% since 11/04/25 | ||
| Low | 2.28 on 11/21/25 | 6.47 on 12/02/25 | 14.44 on 11/05/25 | ||
| High | 2.60 on 11/06/25 | 10.08 on 11/05/25 | 20.33 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | -0.40% since 09/04/25 | -14.83% since 09/04/25 | +33.10% since 09/04/25 | ||
| Low | 2.28 on 11/21/25 | 6.47 on 12/02/25 | 13.47 on 09/11/25 | ||
| High | 3.16 on 09/29/25 | 10.08 on 11/05/25 | 20.33 on 11/28/25 | ||
| 6-Month | |||||
| %Chg | +29.02% since 06/04/25 | +51.69% since 06/04/25 | +69.85% since 06/04/25 | ||
| Low | 1.84 on 06/23/25 | 4.30 on 06/13/25 | 10.42 on 06/17/25 | ||
| High | 3.16 on 09/29/25 | 10.08 on 11/05/25 | 20.33 on 11/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 961,061 | 1,116,669 | 957,194 | ||
| Shares Outstanding, K | 382,893 | 165,924 | 50,672 | ||
| Annual Sales | 117,620,000 | 203,070,000 | 64,380,000 | ||
| Annual Net Income | 41,080,000 | -54,840,000 | -56,420,000 | ||
| Last Quarter Sales | 36,340,000 | 74,380,000 | 19,990,000 | ||
| Last Quarter Net Income | -6,570,000 | 620,000 | 3,620,000 | ||
| 60-Month Beta | 0.66 | 0.57 | 0.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.07 on 11/06/25 | 0.00 on 11/06/25 | 0.04 on 11/10/25 | ||
| Latest Earnings Date | 11/06/25 | 11/06/25 | 11/10/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 39.21 | ||